Castle Biosciences (CSTL) Gross Profit Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.50% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 12.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.47% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 119.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 12.13% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 8.91% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | 16.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.46% |
| Mar 31, 2026 | -11.81% |
| Dec 31, 2025 | -2.04% |
| Sep 30, 2025 | -8.31% |
| Jun 30, 2025 | -5.41% |
| Mar 31, 2025 | 21.20% |
| Dec 31, 2024 | 30.60% |
| Sep 30, 2024 | 39.86% |
| Jun 30, 2024 | 85.47% |
| Mar 31, 2024 | 85.47% |
| Dec 31, 2023 | 86.33% |
| Sep 30, 2023 | 78.23% |
| Jun 30, 2023 | 43.93% |
| Mar 31, 2023 | 52.36% |
| Dec 31, 2022 | 40.97% |
| Sep 30, 2022 | 48.36% |
| Jun 30, 2022 | 42.45% |
| Mar 31, 2022 | 5.68% |
| Dec 31, 2021 | 39.76% |
| Sep 30, 2021 | 48.92% |